About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 421 record(s)
Req # A-2020-001443
Adverse Reaction Reports (AERs) for DOCETAXEL. Report numbers: 912494, 912544, 913311, 914722, 914781, 915869, E2B_03015124, E2B_03037091, E2B_03127152, E2B_03144247, E2B_03167805, E2B_03134684, E2B_03144553, E2B_03070750.Organization: Health Canada
June 2021
Req # A-2020-001444
Adverse Reaction Reports (AERs) for GLYCERYL TRINITRATE. Report numbers: 737561, 913042, E2B_03007028, E2B_03093978, E2B_03098060, E2B_03072888.Organization: Health Canada
June 2021
Req # A-2020-001818
Adverse Reaction Reports (AERs). Report numbers: E2B_01934229, E2B_01995214, E2B_02177933, E2B_02098008, E2B_02114908, E2B_02163268, E2B_02262256, E2B_02292814, 000723107, E2B_02386543, E2B_02417349, 000727221, E2B_02476019, E2B_02560187, E2B_02571761, E2B_02597195, E2B_02605158, E2B_02608027, E2B_02617867, E2B_02720298.Organization: Health Canada
June 2021
Req # A-2021-000216
Adverse Drug Reaction (ADR). Report number: 000935256.Organization: Health Canada
June 2021
Req # A-2021-000195
Adverse Reaction Reports (AERs). Report numbers: E2B_03570042, E2B_03571633, E2B_03571647, 03572110, E2B_03573660, E2B_03573661, E2B_03573672, E2B_03574197, E2B_03574199, E2B_03575347, E2B_03576645, E2B_03576658.Organization: Health Canada
June 2021
Req # A-2020-000521
Adverse Reaction Reports (AERs) for CLOFARABINE. Report numbers: 732195, 732496.Organization: Health Canada
June 2021
Req # A-2020-001501
Adverse Reaction Reports (AERs). Report numbers: E2B_02906005, E2B_03203899, E2B_03331242, E2B_03304752, E2B_03291829.Organization: Health Canada
June 2021
Req # A-2020-001502
Adverse Reaction Reports (AERs). Report numbers: E2B_02984529, E2B_02984533, E2B_02984875, E2B_02985343, E2B_02985683, E2B_02985711, E2B_02985739, E2B_02986057, E2B_02986197, E2B_02986771, E2B_02986847, E2B_02986851, E2B_02986871, E2B_02987919, E2B_02988093, E2B_02988422, E2B_02988934, E2B_02989662, E2B_02989687, E2B_02990973.Organization: Health Canada
June 2021
Req # A-2020-001567
Adverse Reaction Reports (AERs). Report numbers: E2B_03194660, E2B_03194957, E2B_03195575, E2B_03195849, E2B_03195898, E2B_03196070, E2B_03196098, E2B_03196864, E2B_03196988, E2B_03197027, E2B_03197046, E2B_03197166, E2B_03197322, E2B_03198230, E2B_03198282, E2B_03198292, E2B_03198390, E2B_03198780, E2B_03198877, E2B_03198950.Organization: Health Canada
June 2021
Req # A-2020-001641
Adverse Reaction Reports (AERs) for LEUPROLIDE ACETATE. Report numbers: E2B_03269527, E2B_03195567, 000915421, 000917735.Organization: Health Canada
June 2021